Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. J Thorac Oncol. 2010 Jul; 5(7):1048-53.
View in:
PubMed
subject areas
Adenocarcinoma
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Cell Proliferation
Female
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Quinazolines
Retrospective Studies
Survival Rate
Treatment Outcome
Tumor Cells, Cultured
authors with profiles
Mark Stephen Huberman, M.D.
Daniel Geoffrey Tenen, M.D.
Daniel Botelho Costa, Ph.D., M.D.
Susumu Kobayashi, M.D.
Beow Yong Yeap, Sc.D.
Kelly Bodio Downey, M.D.